19 min listen
ENP63: Vosoritide and Children With Genetic Short Stature
ENP63: Vosoritide and Children With Genetic Short Stature
ratings:
Length:
15 minutes
Released:
Nov 30, 2022
Format:
Podcast episode
Description
We look at Vosoritide, a promising, potential treatment for children with genetic short stature who do not have chondrodysplasia. Host Aaron Lohr talks with Andrew Dauber, MD, division chief of endocrinology at Children’s National Hospital. Dr. Dauber and colleagues presented about Vosoritide at ENDO 2022. Their abstract is titled, “A Prospective Clinical Trial of Vosoritide in Selected Genetic Causes of Short Stature.” For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast
Released:
Nov 30, 2022
Format:
Podcast episode
Titles in the series (70)
ENP20: Burosumab by Endocrine News Podcast